Responding to an invitation from Springer Publishing, Aker BioMarine Antarctic has completed a comprehensive chapter on krill phospholipid omega-3 fatty acids for the book Omega-6/3 Fatty Acids, which is now available for purchase. The chapter, titled "Recent Findings on Cardiovascular and Mental Health Effects of Krill Oil and Omega-3 Phospholipids," discusses the latest research and developments regarding phospholipid omega-3 fatty acids in relation to heart and brain health.
While the other chapters discuss the many health benefits of long-chain omega-3 fatty acids, the chapter on krill explains its value as a novel source of phospholipid omega-3 fatty acids. It also goes into great detail regarding the therapeutic benefits of krill phospholipid omega-3 fatty acids.
In particular, the book chapter explains how krill phospholipid omega-3 fatty acids balance the body's omega-6 to omega-3 ratio. It also underlines the ability of krill phospholipid omega-3 fatty acids to affect gene expression profiles and endocannabinoid precursor availabilities. Through these means, omega-3 fatty acids from krill may lower triglyceride levels and reduce fat deposition in and around organs. It may also alleviate inflammatory states implicated in atherogenesis and subsequently increased cardiovascular risk.
The book chapter also focuses on the brain health benefits of krill phospholipid omega-3 fatty acid intake and specifically its effects on memory. Research continues to substantiate the increased uptake of phospholipid omega-3 DHA from krill in brain tissue compared to other omega-3 fatty acid sources.
According to the book chapter author, Lena Burri, director of scientific writing, Aker BioMarine Antarctic, "Krill phospholipid omega-3 fatty acids remain an interesting segment of the industry, and their bio-efficient delivery continues to gain a lot of attention. This book chapter offers a comprehensive look at phospholipid omega-3 fatty acids and highlights their unique attributes in several health areas."
As part of an established commitment to substantiating krill's health benefits, Aker BioMarine Antarctic continues to sponsor in vitro, in vivo, and human clinical trials, which consistently demonstrate a higher uptake of phospholipid omega-3 fatty acids. Aker BioMarine Antarctic is a krill ingredient marketer that is primary in its supply. The company's proprietary Eco-Harvesting technology and on-board processing result in the unique composition of Superba Krill Oil and provide full traceability from sea to shelf. The Marine Stewardship Council (MSC) has granted MSC Certification to Aker BioMarine Antarctic's fisheries, an exclusive distinction that no other krill fishery has earned.